What Is a Cannabis MSO and Why Do People Hate Them

The term gets thrown around constantly in cannabis industry coverage. MSO this. MSO that. MSO consolidation. MSO bankruptcy. MSO cartel. If you're not deep in cannabis trade press, the acronym shows up like a piece of jargon you're supposed to already know. Here's what it actually means, who the major players are, and why the term has become a kind of insult in much of the cannabis world.

The Definition

MSO stands for Multi-State Operator. In cannabis, an MSO is a company that holds cannabis licenses and operates cannabis businesses in two or more states.

That's it. That's the technical definition.

In practice, the term refers more specifically to large, often publicly-traded cannabis companies operating across multiple states with vertical integration — meaning they cultivate, process, distribute, and sell cannabis through their own retail locations rather than relying on third parties for any of those functions. The largest MSOs operate in a dozen or more states, with combined revenues in the hundreds of millions to billions of dollars annually.

A small operator with a license in one state is not an MSO. A two-state operator technically meets the definition but isn't usually what people mean when they use the term. When the cannabis industry says "MSO," they mean the dominant national operators — Curaleaf, Trulieve, Green Thumb Industries, Cresco Labs, Verano, and a dozen or so similar-scale companies.

How Cannabis MSOs Came to Exist

The MSO model exists because of the specific regulatory structure of American cannabis legalization.

When states legalized cannabis (medical first, then recreational), each state created its own regulatory framework. Each state issued its own licenses. Each state set its own taxes, testing requirements, security standards, and operational restrictions. The federal government, because cannabis remained federally illegal, played no coordinating role.

The result was 30+ separate state cannabis markets, each with its own rules, none with interstate commerce. A cultivator in California could not legally ship product to a dispensary in New Jersey. A brand established in Colorado could not, technically, exist as the same brand selling in Florida — in each state, the brand had to be re-established under that state's licensing structure.

This created a strategic question for ambitious cannabis operators: how do you build a national-scale business across state lines that don't allow interstate commerce?

The answer was the MSO model. Acquire or apply for licenses in multiple states. Build separate operating subsidiaries in each state, all owned by the same parent company. Replicate the brand and operating model across markets. Centralize management, capital, and corporate functions. Use vertical integration to control the supply chain within each state. Capture economies of scale at the corporate level even if the operations themselves are state-specific.

This model produced the modern cannabis MSO. The largest MSOs spent the late 2010s aggressively acquiring licenses, building cultivation facilities, opening retail locations, and consolidating positions in as many states as their capital allowed.

Why MSOs Have Advantages

The MSO model produces specific competitive advantages over single-state operators.

Capital access. Public listing on Canadian exchanges allows MSOs to raise equity capital at scales impossible for single-state private operators. Larger operations can also access debt capital from cannabis-specialty lenders at terms unavailable to smaller borrowers.

Brand portability. Once a brand is established in one state, replicating it in additional states leverages existing brand recognition, product development, and consumer preferences. Single-state operators have to build brand recognition from scratch in each market they enter.

Operational expertise transfer. Standard operating procedures, supply chain relationships, technology systems, and management practices developed in one state can be applied to operations in additional states with modest adaptation. This produces operational efficiency advantages over single-state operators reinventing wheels.

Procurement scale. MSOs purchasing cultivation supplies, packaging, equipment, and services at multi-state scale can negotiate better pricing than single-state operators buying smaller quantities.

Regulatory expertise. Navigating state cannabis regulation requires substantial expertise. MSOs that have navigated multiple state frameworks build internal capabilities that are valuable when entering additional markets.

Investor confidence. Public market investors generally prefer larger, more diversified operators to smaller, geographically concentrated ones. The MSO model attracts the institutional capital that allows continued growth.

Why People Hate Them

The MSO model also produces specific outcomes that many people in cannabis culture and industry actively resent.

Consolidation crushes small operators. The capital and operational advantages of MSOs allow them to outcompete, acquire, or push out smaller operators in markets they enter. Diverse local cannabis ecosystems get replaced by dispensary chains operating identical store designs, identical product portfolios, and identical pricing across geographies.

Cartel-like behavior in concentrated markets. The Ohio AG complaint of February 2026 alleged that nine major MSOs were coordinating prices, sharing competitively sensitive information, and allocating shelf space across state lines. The behavior, if proven, is essentially cartel conduct that benefits MSOs at the expense of consumers, smaller operators, and independent brands.

Equity exclusion. Despite cannabis legalization's marketing emphasis on repairing the harms of prohibition, the MSO-dominated industry that emerged has Black ownership in low single-digit percentages. The MSOs that benefited most from legalization are not, in most cases, owned or led by people from the communities most harmed by prohibition.

Worker pay structures. MSO executive compensation runs into the seven and eight figures while budtenders make $16-22 per hour and face the highest workplace risks. The pay gap is extreme even by general American corporate standards.

Quality compromises at scale. Mass-market MSO product often involves compromises on cultivation practices, ingredient quality, and customer service that single-state craft operators don't make. The pesticide recalls and lab fraud documented across multiple states have disproportionately involved MSO-supplied product.

Tax avoidance at the top while small operators pay. The MSOs collectively owe the IRS over $1.6 billion in unpaid 280E taxes, withholding payment as part of a litigation strategy. Smaller operators paying their own 280E taxes quarterly cannot afford the same approach.

Cultural extraction. Cannabis culture, substantially built by communities of color over decades of prohibition, has been commercially extracted by MSOs whose ownership and leadership do not reflect that origin. The aesthetics, language, and consumer expectations developed by cannabis communities are now monetized by operations that have no connection to those communities.

Lobbying that prioritizes MSO interests over equity, worker, or consumer interests. The federal cannabis lobbying agenda is substantially shaped by MSO trade associations. The priorities — banking access, rescheduling, tax relief — primarily benefit MSO operations. Equity provisions, worker protections, and consumer-focused reforms are not prioritized.

The Major MSOs You Should Know

If you want to understand cannabis industry coverage, knowing the major MSOs by name helps.

Curaleaf Holdings. Largest U.S. cannabis MSO by revenue. Operations in 17+ states. Carries the largest cannabis sector debt load. Founder/chairman Boris Jordan. Public on Toronto Stock Exchange (CURA).

Trulieve Cannabis Corp. Florida-anchored with operations across roughly 9 states. Co-founded and led by Kim Rivers. Public on Canadian Securities Exchange (TRUL).

Green Thumb Industries. Operates RISE Dispensaries chain across 14+ states. Founded and led by Ben Kovler. Generally regarded as one of the better-managed MSOs financially. Public on Canadian Securities Exchange (GTII).

Cresco Labs. Operates Sunnyside dispensary chain across 9+ states. Founded by Charlie Bachtell. Public on Canadian Securities Exchange (CL).

Verano Holdings. Operates Zen Leaf dispensaries across 13+ states. Founded by George Archos. Public on Canadian Securities Exchange (VRNO).

Ascend Wellness Holdings. Operations across 6+ states. CEO Abner Kurtin. Public on Canadian Securities Exchange (AAWH).

Glass House Brands. Primarily California-focused with greenhouse cultivation strategy. Co-founded by Kyle Kazan and Graham Farrar. Public on NEO Exchange (GLAS.A.U).

The Cannabist Co. (formerly Columbia Care). Operations across multiple states; filed for bankruptcy in March 2026.

TerrAscend. Operations across multiple states. Public on Toronto Stock Exchange.

Schwazze (Medicine Man Technologies). Rocky Mountain regional operator. Public on OTCQX (SHWZ).

Cannabist Co., Jushi Holdings, Acreage Holdings, Vireo Health, Body and Mind, MariMed. Mid-tier MSOs with smaller footprints.

PharmaCann. Privately held; operations across 6+ states.

These companies, along with a handful of smaller and regional operators, dominate the regulated U.S. cannabis market.

What Industry Coverage Says About Them

When cannabis trade publications, financial press, and consumer media cover MSOs, they typically cover specific recurring themes.

Quarterly earnings. MSO financial performance, market share trends, and forward guidance receive substantial trade press attention. The financials reveal the actual operating performance behind the marketing claims.

Regulatory actions. State and federal regulatory actions against MSOs — license revocations, recall actions, antitrust complaints — are reliably covered.

Acquisitions and divestitures. MSO M&A activity drives substantial industry change. Coverage of acquisitions reveals competitive dynamics and consolidation trends.

Bankruptcy and restructuring. Cannabis sector debt issues and the resulting restructurings have become major coverage areas as the debt wall arrives.

Executive compensation and governance. Executive pay, board composition, and corporate governance issues at MSOs receive periodic coverage.

The depth and quality of coverage varies. Trade publications dependent on MSO advertising face structural difficulties covering MSOs critically. Independent cannabis journalism, including this publication, prioritizes the coverage that captive trade press cannot do.

What This Means for You

If you are a cannabis consumer, knowing what MSOs are and which dispensaries belong to them changes your purchasing decisions in specific ways.

MSO retail vs. independent retail produces different experiences. MSO dispensary chains offer consistency, predictable product portfolios, and competitive pricing on house brands. Independent dispensaries typically offer wider brand portfolios, more local product, and more personalized customer service. Both models have merit; they're optimized for different things.

MSO house brands vs. independent brands are different products. MSO house brands are produced for scale at price points that allow MSO retail to compete on value. Independent brands often produce higher-quality product at higher prices. The price-quality tradeoff is real.

MSO ownership of the dispensary affects which brands are stocked. MSO retail typically prioritizes its own house brands and brands from reciprocal-supply partners. Independent brands have substantially less shelf access at MSO retail than at independent retail.

Worker conditions vary by operator. Some MSO operators have constructive labor relations and reasonable wage structures. Others do not. Some independent operators pay better than MSOs; others pay worse. The variation is substantial.

If you are a cannabis worker, understanding which MSOs operate which retail and cultivation facilities affects which job opportunities exist in your market and what conditions to expect.

If you are a small operator or aspiring entrepreneur, understanding the MSO landscape affects competitive positioning, capital strategy, and partnership decisions.

The Honest Bottom Line

MSOs are not unique to cannabis. Multi-state operating companies dominate most American consumer industries. The pattern of national chains displacing local operators is a generic feature of American capitalism, not a cannabis-specific phenomenon.

What is specific to cannabis is the extent to which the MSO model contradicts the marketing claims of the legalization movement. Cannabis legalization was sold as repair for prohibition harms. The MSOs that came to dominate the legalized industry are, in most cases, not connected to those repair commitments and have, in some cases, structurally worked against them.

This creates the disconnect that produces the resentment. The industry got built. The promises that built it got broken. The companies that benefit most from the current structure are the companies most insulated from the consequences of breaking the promises.

That is what people mean when they say MSO with hostility. It's not the abstract idea of multi-state operations. It's the specific pattern of behavior that the dominant U.S. cannabis MSOs have demonstrated and that, increasingly, regulators and journalists are forcing into public view.

Now you know.

---

Internal links:

• The MSO Cartel: Inside the Price-Fixing Lawsuit →
• The 12 MSOs That Control American Cannabis →
• Why Black-Owned Cannabis Brands Can't Get Shelf Space →